The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pharmaceutical company funding and its consequences: A qualitative systematic review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“performed a similar systematic review, of the quantitative analyses of the relationships between research funding and outcomes, methodology, or publication; this review was broader in dates (1966–2002) and in languages of publication [4].”
MethodScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816 · cited 1×
“They found eight analyses comparing outcomes for trials funded by industry (mostly, but not all pharmaceutical) and other sources [2].”
BackgroundAls-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schünemann, H. J., Sprague, S., Mears, D., Schemitsch, E. H., Heels-Ansdell, D., & Devereaux, P. J. (2004) · Europe PMC (PubMed Central) · Cited by 551
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Jørgensen, A. W., Hilden, J., & Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38973.444699.0b · Cited by 444
Bias in published cost effectiveness studies: systematic review
Bell, C. M., Urbach, D. R., Ray, J. G., Bayoumi, A., Rosen, A. B., Greenberg, D., & Neumann, P. J. (2006) · BMJ · doi:10.1136/bmj.38737.607558.80 · Cited by 382
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Ridker, P. M., & Torres, J. (2006) · JAMA · doi:10.1001/jama.295.19.2270 · Cited by 303
Cited by
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Cohen, J. F., Korevaar, D. A., Altman, D. G., Bruns, D. E., Gatsonis, C. A., Hooft, L., Irwig, L., Levine, D., Reitsma, J. B., de Vet, H. C. W., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012799 · Cited by 2,570
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
Fanelli, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005738 · Cited by 1,911
“This would support growing fears that the large financial interests that often drive medical research are severely biasing it [50], [51], [52].”
BackgroundMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
Industry sponsorship and research outcome
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub2 · Cited by 605
Self-citationSchellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520
Reporting bias in medical research - a narrative review
McGauran, N., Wieseler, B., Kreis, J., Schüler, Y.-B., Kölsch, H., & Kaiser, T. (2010) · Trials · doi:10.1186/1745-6215-11-37 · Cited by 452
Margulis, A. V., Pladevall, M., Riera-Guardia, N., Varas-Lorenzo, C., Hazell, L., Berkman, N., Viswanathan, M., & Perez-Gutthann, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s66677 · Cited by 441
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
Vedula, S. S., Bero, L., Scherer, R. W., & Dickersin, K. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0906126 · Cited by 361
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 307
Newer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
“Research has shown that across different health fields, pharmaceutically funded studies are more likely to have results favouring the pharmaceutical company’s product (Lexchin 2003; Sismondo 2008).”
BackgroundSismondo, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040286 · Cited by 259
Self-citationResponsible Conduct of Research
Shamoo, A. E., & Resnik, D. B. (2022) · doi:10.1093/oso/9780197547090.001.0001 · Cited by 224
Tate, R. L., Perdices, M., Rosenkoetter, U., McDonald, S., Togher, L., Shadish, W., Horner, R., Kratochwill, T., Barlow, D. H., Kazdin, A., et al. (2016) · Archives of Scientific Psychology · doi:10.1037/arc0000027 · Cited by 219
Industry sponsorship and research outcome: systematic review with meta-analysis
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5293-7 · Cited by 162
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments
Roseman, M. (2011) · JAMA · doi:10.1001/jama.2011.257 · Cited by 145
Simera, I., Moher, D., Hoey, J., Schulz, K. F., & Altman, D. G. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.011 · Cited by 97
Hansen, C., Lundh, A., Rasmussen, K., & Hróbjartsson, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000047.pub2 · Cited by 96
The promise and perils of industry‐funded science
Holman, B., & Elliott, K. C. (2018) · Philosophy Compass · doi:10.1111/phc3.12544 · Cited by 88
de Winter, J. C., & Dodou, D. (2015) · PeerJ · doi:10.7717/peerj.733 · Cited by 78
Naci, H., Dias, S., & Ades, A. E. (2014) · BMJ · doi:10.1136/bmj.g5741 · Cited by 61
Science, Values, and the New Demarcation Problem
Resnik, D. B., & Elliott, K. C. (2023) · Journal for General Philosophy of Science · doi:10.1007/s10838-022-09633-2 · Cited by 49
“Deciding which studies to include in the review of evidence can be a difficult task, because research has shown that clinical trials funded by drug companies often reflect the company’s bias (for a review of the evidence, see Krimsky 2003; Sismondo 2008; McGarity and Wagner 2008).”
BackgroundInstitutional Conflict of Interest Policies at U.S. Academic Research Institutions
Resnik, D. B., Ariansen, J. L., Jamal, J., & Kissling, G. E. (2016) · Academic Medicine · doi:10.1097/acm.0000000000000980 · Cited by 49
Institutional Conflicts of Interest in Academic Research
Resnik, D. B. (2019) · Science and Engineering Ethics · doi:10.1007/s11948-015-9702-9 · Cited by 40
“There is a sizeable body of evidence demonstrating that sources of funding and investigator’s financial interests can influence research outcomes (Friedberg et al. 1999; Krimsky 2003; Lexchin et al. 2003; Resnik 2007; Ridker and Torres 2006; Sismondo 2008; Stelfox et al. 1998).”
Science and money: problems and solutions
Resnik, D. B. (2014) · Journal of Microbiology & Biology Education · doi:10.1128/jmbe.v15i2.792 · Cited by 33
“Three systematic reviews of over 40 publications examining the relationship between sources of funding and research outcomes found that studies with industry funding were more likely to report results that favored the company’s products than studies with independent sources of funding (6, 2, 13).”
Pereira, M. M. A., Dini, C., Souza, J. G. S., Barão, V. A. R., & de Avila, E. D. (2024) · The Journal of Prosthetic Dentistry · doi:10.1016/j.prosdent.2022.05.026 · Cited by 14
How Metrics-Based Academic Evaluation Could Systematically Induce Academic Misconduct: A Case Study
Han, J., & Li, Z. (2018) · East Asian Science, Technology and Society: An International Journal · doi:10.1215/18752160-4275144 · Cited by 13
Saa, C., Bunout, D., & Hirsch, S. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001322 · Cited by 10
Metadata
- Authors
- Sismondo, S.
- Venue
- Contemporary Clinical Trials
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 29
- Issue
- 2
- Pages
- 109-113
- ISSN
- 1551-7144 (ISSN-L)
- OpenAlex
- W2031244707
- Cited by
- 304
- References
- 30
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.